Serotonin 6 receptor gene and mood disorders: Case-control study and meta-analysis

Neuroscience Research

Volumn 67, Issue 3, 2010, Pages 250-255

  Fukuo, Yasuhisa ^a   Kishi, Taro ^a   Yoshimura, Reiji ^b   Kitajima, Tsuyoshi ^a   Okochi, Tomo ^a   Yamanouchi, Yoshio ^a   Kinoshita, Yoko ^a   Kawashima, Kunihiro ^a   Naitoh, Hiroshi ^a   Umene Nakano, Wakako ^b   Inada, Toshiya ^c   Kunugi, Hiroshi ^d   Kato, Tadafumi ^e   Yoshikawa, Takeo ^e   Ujike, Hiroshi ^f   Nakamura, Jun ^b   Ozaki, Norio ^g   Iwata, Nakao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c SEIWA HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^e RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bipolar disorder (BP); Case control study; Major depressive disorder (MDD); Meta analysis; Serotonin 6 receptor gene (HTR6); Tagging SNP

Indexed keywords

SEROTONIN 6 RECEPTOR;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOOD DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SEROTONIN; SAMPLE SIZE;

EID: 77953361787     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.04.003     Document Type: Article

References (53)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
2. Bymaster F.P., Falcone J.F., Bauzon D., Kennedy J.S., Schenck K., DeLapp N.W., Cohen M.L. Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. Eur. J. Pharmacol. 2001, 430(2-3):341-349.
3. Chalmers D.T., Watson S.J. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 1991, 561(1):51-60.
4. Cheng R., Juo S.H., Loth J.E., Nee J., Iossifov I., Blumenthal R., Sharpe L., Kanyas K., Lerer B., Lilliston B., Smith M., Trautman K., Gilliam T.C., Endicott J., Baron M. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol. Psychiatry 2006, 11(3):252-260.
5. Consortium W.T.C.C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.
6. DeBattista C., Hawkins J. Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs 2009, 23(5):369-377.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7(3):177-188.
8. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 2003, 25(2):115-121.
9. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St C.D., Robinson M., Van Beck M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40(9):1056-1058.
10. Fone K.C. An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacology 2008, 55(6):1015-1022.
11. Gerard C., Martres M.P., Lefevre K., Miquel M.C., Verge D., Lanfumey L., Doucet E., Hamon M., el Mestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 1997, 746(1-2):207-219.
12. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19(3):376-382.
13. Harmer C.J. Serotonin and emotional processing: does it help explain antidepressant drug action?. Neuropharmacology 2008, 55(6):1023-1028.
14. Hattori E., Toyota T., Ishitsuka Y., Iwayama Y., Yamada K., Ujike H., Morita Y., Kodama M., Nakata K., Minabe Y., Nakamura K., Iwata Y., Takei N., Mori N., Naitoh H., Yamanouchi Y., Iwata N., Ozaki N., Kato T., Nishikawa T., Kashiwa A., Suzuki M., Shioe K., Shinohara M., Hirano M., Nanko S., Akahane A., Ueno M., Kaneko N., Watanabe Y., Someya T., Hashimoto K., Iyo M., Itokawa M., Arai M., Nankai M., Inada T., Yoshida S., Kunugi H., Nakamura M., Iijima Y., Okazaki Y., Higuchi T., Yoshikawa T. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(8):1110-1117.
15. Hirst W.D., Minton J.A., Bromidge S.M., Moss S.F., Latter A.J., Riley G., Routledge C., Middlemiss D.N., Price G.W. Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue. Br. J. Pharmacol. 2000, 130(7):1597-1605.
16. Hong C.J., Tsai S.J., Cheng C.Y., Liao W.Y., Song H.L., Lai H.C. Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders. Am. J. Med. Genet. 1999, 88(6):601-602.
17. Illi A., Setala-Soikkeli E., Viikki M., Poutanen O., Huhtala H., Mononen N., Lehtimaki T., Leinonen E., Kampman O. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 2009, 20(12):1125-1128.
18. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 2007, 61(1):3-19.
19. Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., Okochi T., Aleksic B., Tomita M., Okada T., Kunugi H., Inada T., Ozaki N., Iwata N. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr. Res. 2009.
20. King M.V., Marsden C.A., Fone K.C. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol. Sci. 2008, 29(9):482-492.
21. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Inada T., Ozaki N., Iwata N. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259(5):293-297.
22. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Ozaki N., Iwata N. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. Neuromolecular Med. 2009, 11(2):53-57.
23. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Ozaki N., Iwata N. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci. Res. 2008, 62(4):211-215.
24. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Ozaki N., Iwata N. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population. Neuropsychobiology 2009, 59(4):234-238.
25. Kishi T., Kitajima T., Tsunoka T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Inada T., Ozaki N., Iwata N. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population. Neurosci. Res. 2009, 64(2):231-234.
26. Kishi T., Kitajima T., Tsunoka T., Okumura T., Ikeda M., Okochi T., Kinoshita Y., Kawashima K., Yamanouchi Y., Ozaki N., Iwata N. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population. Neuromolecular Med. 2009, 11(2):114-122.
27. Kishi T., Tsunoka T., Ikeda M., Kawashima K., Okochi T., Kitajima T., Kinoshita Y., Okumura T., Yamanouchi Y., Inada T., Ozaki N., Iwata N. Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J. Hum. Genet. 2009, 54(11):629-633.
28. Kishi T., Yoshimura R., Kitajima T., Okochi T., Okumura T., Tsunoka T., Yamanouchi Y., Kinoshita Y., Kawashima K., Naitoh H., Nakamura J., Ozaki N., Iwata N. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. Neuromolecular Med. 2009.
29. Kohen R., Metcalf M.A., Khan N., Druck T., Huebner K., Lachowicz J.E., Meltzer H.Y., Sibley D.R., Roth B.L., Hamblin M.W. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem. 1996, 66(1):47-56.
30. Kong A., Steinthorsdottir V., Masson G., Thorleifsson G., Sulem P., Besenbacher S., Jonasdottir A., Sigurdsson A., Kristinsson K.T., Jonasdottir A., Frigge M.L., Gylfason A., Olason P.I., Gudjonsson S.A., Sverrisson S., Stacey S.N., Sigurgeirsson B., Benediktsdottir K.R., Sigurdsson H., Jonsson T., Benediktsson R., Olafsson J.H., Johannsson O.T., Hreidarsson A.B., Sigurdsson G., Ferguson-Smith A.C., Gudbjartsson D.F., Thorsteinsdottir U., Stefansson K. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462(7275):868-874.
31. Kulkarni S.K., Dhir A. Current investigational drugs for major depression. Expert Opin. Investig. Drugs 2009, 18(6):767-788.
32. Le Francois B., Czesak M., Steubl D., Albert P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008, 55(6):977-985.
33. Lee S.H., Lee K.J., Lee H.J., Ham B.J., Ryu S.H., Lee M.S. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry Clin. Neurosci. 2005, 59(2):140-145.
34. Levinson D.F. The genetics of depression: a review. Biol. Psychiatry 2006, 60(2):84-92.
35. Malhi G.S., Adams D., Berk M. Medicating mood with maintenance in mind: bipolar depression pharmacotherapy. Bipolar Disord. 2009, 11(Suppl. 2):55-76.
36. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
37. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22(4):719-748.
38. Nash M.W., Huezo-Diaz P., Williamson R.J., Sterne A., Purcell S., Hoda F., Cherny S.S., Abecasis G.R., Prince M., Gray J.A., Ball D., Asherson P., Mann A., Goldberg D., McGuffin P., Farmer A., Plomin R., Craig I.W., Sham P.C. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum. Mol. Genet. 2004, 13(19):2173-2182.
39. Neale B.M., Sham P.C. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 2004, 75(3):353-362.
40. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40(9):1053-1055.
41. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., Yamanouchi Y., Tomita M., Inada T., Ozaki N., Iwata N. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr. Res. 2009, 110(1-3):140-148.
42. Papakostas G.I. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J. Clin. Psychiatry 2009, 70(Suppl. 6):16-25.
43. Purohit A., Herrick-Davis K., Teitler M. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor. Synapse 2003, 47(3):218-224.
44. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19(1):149-150.
45. Schumacher J., Kaneva R., Jamra R.A., Diaz G.O., Ohlraun S., Milanova V., Lee Y.A., Rivas F., Mayoral F., Fuerst R., Flaquer A., Windemuth C., Gay E., Sanz S., Gonzalez M.J., Gil S., Cabaleiro F., del Rio F., Perez F., Haro J., Kostov C., Chorbov V., Nikolova-Hill A., Stoyanova V., Onchev G., Kremensky I., Strauch K., Schulze T.G., Nurnberg P., Gaebel W., Klimke A., Auburger G., Wienker T.F., Kalaydjieva L., Propping P., Cichon S., Jablensky A., Rietschel M., Nothen M.M. Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. Am. J. Hum. Genet. 2005, 77(6):1102-1111.
46. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., de Bakker P.I., Ogdie M.N., Thase M.E., Sachs G.S., Todd-Brown K., Gabriel S.B., Sougnez C., Gates C., Blumenstiel B., Defelice M., Ardlie K.G., Franklin J., Muir W.J., McGhee K.A., MacIntyre D.J., McLean A., VanBeck M., McQuillin A., Bass N.J., Robinson M., Lawrence J., Anjorin A., Curtis D., Scolnick E.M., Daly M.J., Blackwood D.H., Gurling H.M., Purcell S.M. Whole-genome association study of bipolar disorder. Mol. Psychiatry 2008, 13(6):558-569.
47. Tohen M., Sutton V.K., Calabrese J.R., Sachs G.S., Bowden C.L. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. J. Affect Disord. 2009, 116(1-2):43-50.
48. Tohen M., Vieta E. Antipsychotic agents in the treatment of bipolar mania. Bipolar Disord. 2009, 11(Suppl. 2):45-54.
49. Tohen M., Vieta E., Goodwin G.M., Sun B., Amsterdam J.D., Banov M., Shekhar A., Aaronson S.T., Bardenstein L., Grecu-Gabos I., Tochilov V., Prelipceanu D., Oliff H.S., Kryzhanovskaya L., Bowden C. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. J. Clin. Psychiatry 2008, 69(11):1776-1789.
50. Vazza G., Bertolin C., Scudellaro E., Vettori A., Boaretto F., Rampinelli S., De Sanctis G., Perini G., Peruzzi P., Mostacciuolo M.L. Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol. Psychiatry 2007, 12(1):87-93.
51. Vogt I.R., Shimron-Abarbanell D., Neidt H., Erdmann J., Cichon S., Schulze T.G., Muller D.J., Maier W., Albus M., Borrmann-Hassenbach M., Knapp M., Rietschel M., Propping P., Nothen M.M. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am. J. Med. Genet. 2000, 96(2):217-221.
52. Wesolowska A., Nikiforuk A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 2007, 52(5):1274-1283.
53. Wesolowska A., Nikiforuk A., Stachowicz K. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav. Pharmacol. 2007, 18(5-6):439-446.